Harmony Biosciences
HRMY
HRMY
246 hedge funds and large institutions have $1.81B invested in Harmony Biosciences in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 127 increasing their positions, 48 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.25% more ownership
Funds ownership: 88.17% → 92.42% (+4.2%)
10% less capital invested
Capital invested by funds: $2B → $1.81B (-$191M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
246
Holding in Top 10
4
Calls
$4.24M
Puts
$1.75M
Top Buyers
| 1 | +$49.8M | |
| 2 | +$45.1M | |
| 3 | +$43.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$41.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$19.9M |
Top Sellers
| 1 | -$158M | |
| 2 | -$104M | |
| 3 | -$15.1M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.9M |
| 5 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$3.88M |